Biohaven Pharmaceutical
North America, Connecticut, United States, New Haven
Description
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
Investor Profile
Biohaven Pharmaceutical has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Medical, Pharmaceutical.
Stage Focus
- Series A (67%)
- Series B (33%)
Country Focus
- United States (100%)
Industry Focus
- Health Care
- Medical
- Pharmaceutical
- Biopharma
- Biotechnology
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
